Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26253 | 20830238 | Int J Clin Exp Pathol | Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation. | 2010 | Details |
| A26254 | 20828853 | J Hepatol | Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. | 2010 | Details |
| A26310 | 20664312 | Korean J Gastroenterol | [Nonalcoholic fatty liver disease]. | 2010 | Details |
| A26313 | 20661154 | J Clin Gastroenterol | Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis. | 2011 | Details |
| A26316 | 20658156 | J Gastroenterol | Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26318 | 20655714 | J Nutr Biochem | Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice. | 2010 | Details |
| A26320 | 20654606 | Clin Chim Acta | The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels. | 2010 | Details |
| A26329 | 20645852 | Annu Rev Nutr | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | 2010 | Details |
| A26350 | 20608031 | Lik Sprava | [Efficiency of complex therapy in the treatment of non-alcoholic steatohepatitis and prevention of liver fibrosis]. | 2010 | Details |
| A26372 | 20576005 | Obes Rev | Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation? | 2011 | Details |
| A26380 | 20560816 | Scand J Gastroenterol | A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis. | 2010 | Details |
| A26382 | 20557969 | J Hepatol | Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. | 2010 | Details |
| A26386 | 20553760 | Prog Lipid Res | Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease. | 2010 | Details |
| A26402 | 20512988 | Hepatology | Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. | 2010 | Details |
| A26421 | 20487204 | J Pharm Pharmacol | Effects of Eriobotrya japonica seed extract on oxidative stress in rats with non-alcoholic steatohepatitis. | 2010 | Details |
| A26422 | 20485253 | Minerva Gastroenterol Dietol | Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26426 | 20473736 | Chin J Integr Med | Effect of Xuezhikang Capsule on serum tumor necrosis factor-alpha and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia. | 2010 | Details |
| A26430 | 20471811 | Exp Toxicol Pathol | Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis. | 2010 | Details |
| A26435 | 20460923 | Dig Dis | Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. | 2010 | Details |
| A26438 | 20460920 | Dig Dis | Genetic and environmental susceptibility to non-alcoholic fatty liver disease. | 2010 | Details |
| A26447 | 20460911 | Dig Dis | Pathology and biopsy assessment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26448 | 20460910 | Dig Dis | Chemokines as immune mediators of liver diseases related to the metabolic syndrome. | 2010 | Details |
| A26449 | 20460909 | Dig Dis | Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. | 2010 | Details |
| A26450 | 20460908 | Dig Dis | The role of cytokines in non-alcoholic fatty liver disease. | 2010 | Details |
| A26466 | 20435456 | J Nutr Biochem | Hyperinsulinemia and ectopic fat deposition can develop in the face of hyperadiponectinemia in young obese rats. | 2011 | Details |
| A26468 | 20432259 | Hepatology | Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. | 2010 | Details |
| A26473 | 20422882 | Hepatogastroenterology | Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD. | 2010 | Details |
| A26478 | 20415685 | Diabetes Obes Metab | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26486 | 20406065 | Biomark Med | Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? | 2010 | Details |
| A26488 | 20402835 | J Dig Dis | Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease. | 2010 | Details |
| A26490 | 20400911 | J Pediatr Gastroenterol Nutr | Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. | 2010 | Details |
| A26494 | 20398192 | Pathol Int | Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26499 | 20392512 | J Hepatol | Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. | 2010 | Details |
| A26501 | 20388146 | Ann N Y Acad Sci | The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26503 | 20387643 | Ukr Biokhim Zh (1999) | Nonalcoholic fatty liver disease: biochemical and therapeutic considerations. | 2010 | Details |
| A26507 | 20379797 | Obes Surg | The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity. | 2010 | Details |
| A26516 | 20370678 | Curr Pharm Des | Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis. | 2010 | Details |
| A26520 | 20370672 | Curr Pharm Des | Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. | 2010 | Details |
| A26525 | 20368739 | Nat Rev Gastroenterol Hepatol | The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. | 2010 | Details |
| A26531 | 20353583 | J Inflamm (Lond) | Elevated endotoxin levels in non-alcoholic fatty liver disease. | 2010 | Details |
| A26532 | 20352596 | Z Gastroenterol | [Histopathological diagnose of non-alcoholic and alcoholic fatty liver disease]. | 2010 | Details |
| A26537 | 20303728 | J Nutr Biochem | Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. | 2010 | Details |
| A26540 | 20300479 | Mediators Inflamm | Inflammatory mediators of hepatic steatosis. | 2010 | Details |
| A26551 | 20221762 | Pathologe | [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines]. | 2010 | Details |
| A26553 | 20216561 | Eur J Clin Nutr | Dietary and physical activity patterns in children with fatty liver. | 2010 | Details |
| A26557 | 20207596 | Dig Liver Dis | From the metabolic syndrome to NAFLD or vice versa? | 2010 | Details |
| A26568 | 20195647 | J Gastroenterol | Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease. | 2010 | Details |
| A26572 | 20188144 | Biochim Biophys Acta | Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFbeta1. | 2010 | Details |
| A26574 | 20185414 | J Lipid Res | Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. | 2010 | Details |
| A26575 | 20182586 | Am J Transl Res | Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. | 2010 | Details |
| A26589 | 20150538 | J Am Soc Nephrol | Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. | 2010 | Details |
| A26593 | 20138495 | J Nutr Biochem | Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. | 2010 | Details |
| A26608 | 20101463 | Dig Dis Sci | Nonalcoholic fatty liver disease: a review and update. | 2010 | Details |
| A26610 | 20096157 | Actas Dermosifiliogr | Cardiometabolic comorbidities and the approach to patients with psoriasis. | 2009 | Details |
| A26611 | 20095887 | Scand J Gastroenterol | Serum chemerin and vaspin in non-alcoholic fatty liver disease. | 2010 | Details |
| A26614 | 20091629 | Cochrane Database Syst Rev | Bariatric surgery for non-alcoholic steatohepatitis in obese patients. | 2010 | Details |
| A26615 | 20088867 | Liver Int | The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. | 2010 | Details |
| A26616 | 20087858 | Mol Nutr Food Res | Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. | 2010 | Details |
| A26637 | 20043126 | Int J Mol Med | Long-term feeding of a synthetic diet rich in disaccharides induces hepatic fibrosis in nonalcoholic fatty liver disease in Zucker rats. | 2010 | Details |
| A26638 | 20042103 | Lipids Health Dis | Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. | 2009 | Details |
| A26647 | 21525758 | Dig Dis | Gut-liver axis and sensing microbes. | 2011 | Details |
| A26683 | 19958638 | Zhonghua Gan Zang Bing Za Zhi | [Clinical and histological features of non-alcoholic fatty liver disease]. | 2009 | Details |
| A26694 | 19942238 | Metabolism | Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. | 2009 | Details |
| A26699 | 19936233 | PLoS One | IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. | 2009 | Details |
| A26701 | 19932590 | Biomed Pharmacother | Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens. | 2009 | Details |
| A26704 | 19929783 | Curr Med Chem | Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance. | 2009 | Details |
| A26718 | 19908945 | J Immunotoxicol | Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. | 2009 | Details |
| A26723 | 19896127 | Atherosclerosis | Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. | 2009 | Details |
| A26724 | 19892897 | Postgrad Med J | The metabolic syndrome: common origins of a multifactorial disorder. | 2009 | Details |
| A26729 | 19886070 | Rom J Intern Med | Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients. | 2009 | Details |
| A26749 | 19839225 | Br J Biomed Sci | Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity. | 2009 | Details |
| A26756 | 19799688 | J Gastroenterol Hepatol | The liver and the waistline: Fifty years of growth. | 2009 | Details |
| A26758 | 19821522 | Hepatology | Activation of the complement system in human nonalcoholic fatty liver disease. | 2009 | Details |
| A26768 | 19818304 | Clin Liver Dis | Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. | 2009 | Details |
| A26773 | 19816994 | Hepatology | Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. | 2009 | Details |
| A26775 | 19811343 | Scand J Gastroenterol | Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. | 2009 | Details |
| A26783 | 19789034 | Surgery | Obesity-induced hepatic hypoperfusion primes for hepatic dysfunction after resuscitated hemorrhagic shock. | 2009 | Details |
| A26785 | 19788606 | J Gastroenterol Hepatol | Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. | 2009 | Details |
| A26796 | 19766963 | Transl Res | Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. | 2009 | Details |
| A26809 | 19740705 | Clin Immunol | The role of resistin as a regulator of inflammation: Implications for various human pathologies. | 2009 | Details |
| A26814 | 19731235 | Hepatology | Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. | 2009 | Details |
| A26820 | 19724016 | Am J Physiol Endocrinol Metab | Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. | 2009 | Details |
| A26821 | 19720629 | J Clin Pathol | Werner syndrome as a possible cause of non-alcoholic steatohepatitis. | 2009 | Details |
| A26824 | 19710104 | Innate Immun | Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis. | 2009 | Details |
| A26828 | 19702660 | J Med Primatol | Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers. | 2009 | Details |
| A26848 | 19664840 | J Hepatol | Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. | 2009 | Details |
| A26852 | 19651758 | Drug Metab Dispos | Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. | 2009 | Details |
| A26854 | 19646834 | Gastroenterol Clin Biol | Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients. | 2009 | Details |
| A26857 | 19637730 | Rev Invest Clin | [Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview]. | 2009 | Details |
| A26869 | 19617184 | Orv Hetil | [Does carbohydrate-deficient transferrin have diagnostic value in non-alcoholic fatty liver disease?]. | 2009 | Details |
| A26870 | 19609863 | Histol Histopathol | Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). | 2009 | Details |
| A26876 | 19601771 | Curr HIV Res | The changing face of HIV/AIDS in treated patients. | 2009 | Details |
| A26925 | 19541928 | Am J Pathol | High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. | 2009 | Details |
| A26929 | 19527485 | Hepatol Res | Sex difference in the liver of hepatocyte-specific Pten-deficient mice: A model of nonalcoholic steatohepatitis. | 2009 | Details |
| A26946 | 19490416 | Liver Int | Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. | 2009 | Details |
| A26963 | 19452403 | Semin Thromb Hemost | Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. | 2009 | Details |
| A26977 | 19423319 | J Nutr Biochem | Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice. | 2009 | Details |
| A26978 | 19422483 | Liver Int | Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. | 2009 | Details |
| A26982 | 19413701 | Obes Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. | 2009 | Details |
| A26998 | 19371271 | Pediatr Int | Ghrelin and leptin modulate immunity and liver function in overweight children. | 2009 | Details |